[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100516291":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":28,"centralContacts":32,"locations":41,"responsibleParty":72,"collaborators":10,"id":75,"slug":76,"hasResults":77,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":10,"eligibilityCriteria":81,"healthyVolunteers":77,"sex":82,"minAge":83,"maxAge":10,"enrollmentInfo":84,"targetDuration":10,"studyType":87,"phases":10,"briefSummary":88,"conditions":89,"keywords":10,"overallStatus":44,"whyStopped":10,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"University of California, Irvine","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Short course of antibiotics",null,"Patients assigned to a 48-hour course of antibiotics. As the current standard of care, the antibiotics used in this treatment are Clindamycin, Vancomycin, Piperacillin-Tazobactam; these antibiotics may be administered combined or individually, based on individualized patient treatment. The specific choice of antibiotic therapy will not be dictated by the study protocol but by the attending surgeon taking care of the patient",[13],"Other: Antibiotic duration (short course)",{"label":15,"type":10,"description":16,"interventionNames":17},"Long course of antibiotics","Patients assigned to a 7 day course of antibiotics. As the current standard of care, the antibiotics used in this treatment are Clindamycin, Vancomycin, Piperacillin-Tazobactam; these antibiotics may be administered combined or individually, based on individualized patient treatment. The specific choice of antibiotic therapy will not be dictated by the study protocol but by the attending surgeon taking care of the patient",[18],"Other: Antibiotic duration (extended course)",[20,24],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"Antibiotic duration (short course)","The patient will be enrolled in a 48-hour course of antibiotics.",[9],{"type":6,"name":25,"description":26,"armGroupLabels":27,"otherNames":10},"Antibiotic duration (extended course)","The patient will be enrolled in a 7 day course of antibiotics.",[15],[29],{"name":30,"affiliation":5,"role":31},"Areg Grigorian, MD","PRINCIPAL_INVESTIGATOR",[33,37],{"name":30,"role":34,"phone":35,"phoneExt":10,"email":36},"CONTACT","8184389093","agrigori@hs.uci.edu",{"name":38,"role":34,"phone":39,"phoneExt":10,"email":40},"Jeffry Nahmias, MD","9493073035","jnahmias@hs.uci.edu",[42],{"facility":43,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"University of California Irvine Medical Center","RECRUITING","Orange","California","92868","United States","US",{"type":51,"coordinates":52},"Point",[53,54],-117.85311,33.78779,{"lat":54,"lon":53},[57,58,59,60,62,64,66,68,70],{"name":30,"role":34,"phone":35,"phoneExt":10,"email":36},{"name":38,"role":34,"phone":39,"phoneExt":10,"email":40},{"name":30,"role":31,"phone":10,"phoneExt":10,"email":10},{"name":38,"role":61,"phone":10,"phoneExt":10,"email":10},"SUB_INVESTIGATOR",{"name":63,"role":61,"phone":10,"phoneExt":10,"email":10},"Sebastian Schubl, MD",{"name":65,"role":61,"phone":10,"phoneExt":10,"email":10},"Lanny L Hsieh, MD",{"name":67,"role":61,"phone":10,"phoneExt":10,"email":10},"Steven E Atallah, PharmD",{"name":69,"role":61,"phone":10,"phoneExt":10,"email":10},"Claudia A Alvarez, MD",{"name":71,"role":61,"phone":10,"phoneExt":10,"email":10},"Negaar Aryan, MD",{"type":31,"investigatorFullName":73,"investigatorTitle":74,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Areg Grigorian","Assistant Clinical Professor, Surgery","100516291","shorter-versus-extended-course-of-antibiotic-therapy-for-necrotizing-soft-tissue-infections-100516291",false,"NCT06002607","Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections","Pilot Randomized Controlled Trial of Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections","Inclusion Criteria:\n\n* Adult patients 18 years of age or older with all following criteria:\n* Presenting to the Emergency Department with history, exam and\u002For imaging concerning NSTI, AND\n* Patients who undergo consultation by the Emergency General Surgery service, AND\n* Patients included must have skin or soft tissue findings consistent with NSTI (erythema, crepitus, or pain out of proportion to exam), AND\n* Systemic signs of infection including fever (temperature \\>38.0°C) or leukocytosis (≥11,000 peripheral white cells per cubic millimeter), AND\n* Patients who undergo excisional debridement and\u002For amputation to achieve source control.\n\nExclusion Criteria:\n\n* Pregnant patients\n* Prisoners\n* Patients with bacteremia upon admission\n* Patients unable to provide consent (including no legally authorized representative)","ALL","18 Years",{"count":85,"type":86},50,"ESTIMATED","OBSERVATIONAL","Necrotizing soft tissue infection (NSTI) is a devastating disease that results in a high rate of in-hospital complications and despite advances in critical care, wound care, and early intervention, NSTI continues to be associated with a mortality rate of nearly 30%. The antibiotics used in this treatment are Clindamycin, Vancomycin, Piperacillin Tazobactam; these antibiotics may be administered combined or individually, based on individualized patient treatment. Although one of the tenets of management for NSTI is early broad-spectrum intravenous antibiotics (listed above), the duration of antibiotics needed is not well defined. Currently, there exists wide variation in the duration of antibiotics for NSTI ranging between 2-16 days. The objective of this study is to evaluate the safety of a shorter course of antibiotics hypothesizing that a short duration of antibiotics for 48-hours after source-control is achieved will have similar risk of morbidity and mortality compared to a 7-day course of antibiotics post source control. A second aim of this study will be to identify if serum procalcitonin levels\u002Fratio correspond to resolution of systemic infection in patients with NSTI.",[90],"Necrotizing Soft Tissue Infection","2026-02-05",{"date":93,"type":94},"2026-02-10","ACTUAL",{"date":96,"type":94},"2023-12-28",{"date":98,"type":86},"2026-12-01",{"name":5,"class":6},1]